Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.48 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.47 |
| ▸ | DAO | P14920 | 2/20 | 0.46 |
| ▸ | CDC7 | O00311 | 1/20 | 0.46 |
| ▸ | DBF4 | Q9UBU7 | 1/20 | 0.46 |
| ▸ | ABL1 | P00519 | 1/20 | 0.45 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.45 |
| ▸ | KDM6B | O15054 | 1/20 | 0.44 |
| ▸ | KDM4A | O75164 | 1/20 | 0.44 |
| ▸ | KDM4D | Q6B0I6 | 1/20 | 0.44 |
| ▸ | HIF1AN | Q9NWT6 | 1/20 | 0.44 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.44 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5155818 | 0.98 | HDAC1 (0.52) | HDAC1HSD17B10NPC1RAB9AGRIN2B | |
| SCHEMBL14355126 | 0.82 | GAA (0.57) | HDAC1NPC1RAB9ATP53PLA2G7 | |
| SCHEMBL4190883 | 0.82 | TAAR1 (0.47) | HDAC1HSD17B10NPC1RAB9AGRIN2B | |
| SCHEMBL31325531 | 0.82 | HTT (0.51) | HDAC1NPC1RAB9ATP53PLA2G7 | |
| SCHEMBL10436025 | 0.79 | KDM4E (0.59) | HDAC1NPC1RAB9ATP53DAO | |
| SCHEMBL8784830 | 0.78 | NPC1 (0.55) | HDAC1NPC1RAB9ATP53DAO | |
| SCHEMBL28722071 | 0.78 | MAPT (0.54) | HDAC1DAOCDC7DBF4MAOB | |
| SCHEMBL9011958 | 0.78 | HDAC1 (0.46) | HDAC1HSD17B10GRIN2BTAAR1GRIN2A | |
| Bromide SCHEMBL10436080 | 0.77 | KDM4E (0.58) | HDAC1NPC1RAB9ATP53DAO | |
| SCHEMBL4765782 | 0.76 | HPGD (0.51) | NPC1RAB9ADAOALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 307 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3586383-B1 | POLYMER PHOTOVOLTAIC CELL WITH AN INVERTED STRUCTURE AND PROCESS FOR ITS PREPARATION | ENI SPA (IT) | 2024-02-14 | — | — | EP | claimed |
| WO-2023194943-A1 | BENZOHETERODIAZOLE COMPOUNDS DISUBSTITUTED WITH DITHIENOPYRROLE GROUPS | ENI S.P.A. (IT) | 2023-10-12 | — | — | WO | claimed |
| US-11374186-B2 | Polymer photovoltaic cell with an inverted structure and process for its preparation | ENI S.P.A. (IT) | 2022-06-28 | — | — | US | claimed |
| US-20200067003-A1 | Polymer Photovoltaic Cell with an Inverted Structure and Process for its Preparation | ENI S.P.A. (IT) | 2020-02-27 | — | — | US | claimed |
| WO-2016131133-A1 | COMPOSITION OF PERACETIC ACID AND AT LEAST ONE ORGANIC FUNGICIDE FOR THE CONTROL OF PATHOGENS IN AND ONTO GROWING PLANTS | AGRI-NEO INC. (CA) | 2016-08-25 | — | — | WO | claimed |
| US-20160222014-A1 | COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS | ASANA BIOSCIENCES, LLC (US) | 2016-08-04 | — | — | US | claimed |
| WO-2015038417-A1 | COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS | ASANA BIOSCIENCES, LLC (US) | 2015-03-19 | — | — | WO | claimed |
| WO-2014188376-A1 | STABILIZED PHOTOACTIVE COMPOSITION AND USE THEREOF | ENI S.P.A. (IT) | 2014-11-27 | — | — | WO | claimed |
| US-20140121386-A1 | P-TYPE ORGANIC SEMICONDUCTOR MATERIAL AND OPTOELECTRONIC DEVICE UTILIZING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2014-05-01 | — | — | US | claimed |
| US-20100292433-A1 | SOLUBLE POLYTHIOPHENE DERIVATIVE | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2010-11-18 | — | — | US | claimed |
| US-7754847-B2 | Homo- and copolymers prepared from fused phenylenedithiophenes which themselves are prepared by intramolecular cyclization of, e.g., a 2,5-di-2-thiophenylterephthalate; used in organic thin film transistors, organic light-emitting diode, and organic solar cells | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2010-07-13 | — | — | US | claimed |
| EP-2075274-B1 | Soluble polythiophene derivatives | IND TECH RES INST (TW) | 2010-06-02 | — | — | EP | claimed |
| US-20090299029-A1 | SOLUBLE POLYTHIOPHENE DERIVATIVES | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2009-12-03 | — | — | US | claimed |
| US-20090171048-A1 | Homo- and copolymers prepared from fused phenylenedithiophenes which themselves are prepared by intramolecular cyclization of, e.g., a 2,5-di-2-thiophenylterephthalate; used in organic thin film transistors, organic light-emitting diode, and organic solar cells | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2009-07-02 | — | — | US | claimed |
| EP-2075274-A1 | Soluble polythiophene derivatives | Industrial Technology Research Institute (TW) | 2009-07-01 | — | — | EP | claimed |
| US-6777531-B2 | POLYMERS USEFUL FOR INCORPORATION INTO ELECTRONIC DEVICES SUCH AS FETS, LEDS AND PHOTOVOLTAIC DEVICES WHICH DO NOT SHOW ANY UNWANTED RED-SHIFT CONTRIBUTION | SONY INTERNATIONAL (EUROPE) GMBH (DE) | 2004-08-17 | — | — | US | claimed |
| EP-1149827-B1 | End-capped polyfluorenes, films and devices based thereon | SONY INT EUROPE GMBH (DE) | 2003-12-10 | — | — | EP | claimed |
| US-20020173617-A1 | End-capped polyfluorenes, films and devices based thereon | SONY DEUTSCHLAND GMBH (DE) | 2002-11-21 | — | — | US | claimed |
| WO-2001081294-A1 | END-CAPPED POLYFLUORENES, FILMS AND DEVICES BASED THEREON | SONY INTERNATIONAL (EUROPE) GMBH (DE) | 2001-11-01 | — | — | WO | claimed |
| EP-1149827-A1 | End-capped polyfluorenes, films and devices based thereon | Sony International (Europe) GmbH (DE) | 2001-10-31 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160222014-A1 | COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS | SRC, PTK2, FYN | HDAC1 1549/4885HSD17B10 4688/4885NPC1 4859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.